Connection

Tanya Turan to Male

Back to Details
This is a "connection" page, showing publications Tanya Turan has written about Male.
Tanya Turan
Connection Strength
0.518
Male
  1. Rationale, Design, and Implementation of Intensive Risk Factor Treatment in the CREST2 Trial. Stroke. 2020 10; 51(10):2960-2971.
    View in: PubMed
    Score: 0.039
  2. Type and Duration of Exercise in the SAMMPRIS Trial. Neurologist. 2019 Jan; 24(1):10-12.
    View in: PubMed
    Score: 0.034
  3. Relationship between Risk Factor Control and Compliance with a Lifestyle Modification Program in the Stenting Aggressive Medical Management for Prevention of Recurrent Stroke in Intracranial Stenosis Trial. J Stroke Cerebrovasc Dis. 2018 Mar; 27(3):801-805.
    View in: PubMed
    Score: 0.032
  4. Light-induced Hemiplegia, an Atypical Case of Retinal Steal Syndrome. Neurologist. 2017 Mar; 22(2):57-60.
    View in: PubMed
    Score: 0.030
  5. Postprandial Clearance of Oxidized Low-Density Lipoprotein in Patients with Stroke Due to Atherosclerosis. J Stroke Cerebrovasc Dis. 2017 Mar; 26(3):488-493.
    View in: PubMed
    Score: 0.030
  6. Yet again no benefit of stenting over medical therapy. Lancet Neurol. 2015 Jun; 14(6):565-6.
    View in: PubMed
    Score: 0.027
  7. The challenge of stroke prevention with intracranial arterial stenosis. Curr Cardiol Rep. 2013 Dec; 15(12):422.
    View in: PubMed
    Score: 0.024
  8. Risk factors associated with severity and location of intracranial arterial stenosis. Stroke. 2010 Aug; 41(8):1636-40.
    View in: PubMed
    Score: 0.019
  9. Failure of antithrombotic therapy and risk of stroke in patients with symptomatic intracranial stenosis. Stroke. 2009 Feb; 40(2):505-9.
    View in: PubMed
    Score: 0.017
  10. Relationship between blood pressure and stroke recurrence in patients with intracranial arterial stenosis. Circulation. 2007 Jun 12; 115(23):2969-75.
    View in: PubMed
    Score: 0.015
  11. Effect of dihydropyridine calcium channel blockers on blood pressure variability in the SPRINT trial: a treatment effects approach. J Hypertens. 2022 03 01; 40(3):462-469.
    View in: PubMed
    Score: 0.011
  12. Hypertensive Disorders of Pregnancy With and Without Prepregnancy Hypertension Are Associated With Incident Maternal Kidney Disease Subsequent to Delivery. Hypertension. 2022 04; 79(4):844-854.
    View in: PubMed
    Score: 0.011
  13. Non-Adherence to Antihypertensive Guidelines in Patients with Asymptomatic Carotid Stenosis. J Stroke Cerebrovasc Dis. 2021 Aug; 30(8):105918.
    View in: PubMed
    Score: 0.010
  14. White Matter Hyperintensity and Cardiovascular Disease Outcomes in the SPRINT MIND Trial. J Stroke Cerebrovasc Dis. 2021 Jun; 30(6):105764.
    View in: PubMed
    Score: 0.010
  15. Maternal Coronary Heart Disease, Stroke, and Mortality Within 1, 3, and 5 Years of Delivery Among Women With Hypertensive Disorders of Pregnancy and Pre-Pregnancy Hypertension. J Am Heart Assoc. 2021 02; 10(5):e018155.
    View in: PubMed
    Score: 0.010
  16. Dual Antiplatelet Therapy Beyond 90 days in Symptomatic Intracranial Stenosis in the SAMMPRIS Trial. J Stroke Cerebrovasc Dis. 2020 Dec; 29(12):105254.
    View in: PubMed
    Score: 0.010
  17. Submaximal Angioplasty for Symptomatic Intracranial Atherosclerotic Disease: A Meta-Analysis of Peri-Procedural and Long-Term Risk. Neurosurgery. 2020 06 01; 86(6):755-762.
    View in: PubMed
    Score: 0.009
  18. The CREST-2 experience with the evolving challenges of COVID-19: A clinical trial in a pandemic. Neurology. 2020 07 07; 95(1):29-36.
    View in: PubMed
    Score: 0.009
  19. Endovascular repair compared with surveillance for patients with small abdominal aortic aneurysms. J Vasc Surg. 2010 May; 51(5):1081-7.
    View in: PubMed
    Score: 0.009
  20. Relationship Between Vascular Risk Factors and Location of Intracranial Atherosclerosis in the SAMMPRIS Trial. J Stroke Cerebrovasc Dis. 2020 May; 29(5):104713.
    View in: PubMed
    Score: 0.009
  21. Carotid revascularization and medical management for asymptomatic carotid stenosis: Protocol of the CREST-2 clinical trials. Int J Stroke. 2017 10; 12(7):770-778.
    View in: PubMed
    Score: 0.008
  22. Nonprocedural Symptomatic Infarction and In-Stent Restenosis After Intracranial Angioplasty and Stenting in the SAMMPRIS Trial (Stenting and Aggressive Medical Management for the Prevention of Recurrent Stroke in Intracranial Stenosis). Stroke. 2017 06; 48(6):1501-1506.
    View in: PubMed
    Score: 0.008
  23. Higher Stroke Risk with Lower Blood Pressure in Hemodynamic Vertebrobasilar Disease: Analysis from the VERiTAS Study. J Stroke Cerebrovasc Dis. 2017 Feb; 26(2):403-410.
    View in: PubMed
    Score: 0.007
  24. Impact of the New American Heart Association/American Stroke Association Definition of Stroke on the Results of the Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis Trial. J Stroke Cerebrovasc Dis. 2017 Jan; 26(1):108-115.
    View in: PubMed
    Score: 0.007
  25. Factors Associated With Recurrent Ischemic Stroke in the Medical Group of the SAMMPRIS Trial. JAMA Neurol. 2016 Mar; 73(3):308-15.
    View in: PubMed
    Score: 0.007
  26. Frequency, Risk Factors, and Outcome of Coexistent Small Vessel Disease and Intracranial Arterial Stenosis: Results From the Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis (SAMMPRIS) Trial. JAMA Neurol. 2016 Jan; 73(1):36-42.
    View in: PubMed
    Score: 0.007
  27. Enrollment volume effect on risk factor control and outcomes in the SAMMPRIS trial. Neurology. 2015 Dec 15; 85(24):2090-7.
    View in: PubMed
    Score: 0.007
  28. Does the Stenting Versus Aggressive Medical Therapy Trial Support Stenting for Subgroups With Intracranial Stenosis? Stroke. 2015 Nov; 46(11):3282-4.
    View in: PubMed
    Score: 0.007
  29. Do Patient Characteristics Explain the Differences in Outcome Between Medically Treated Patients in SAMMPRIS and WASID? Stroke. 2015 Sep; 46(9):2562-7.
    View in: PubMed
    Score: 0.007
  30. Outcome in patients previously on antithrombotic therapy in the SAMMPRIS trial: subgroup analysis. Stroke. 2015 Mar; 46(3):775-9.
    View in: PubMed
    Score: 0.007
  31. Racial differences in poststroke rehabilitation utilization and functional outcomes. Arch Phys Med Rehabil. 2015 Jan; 96(1):84-90.
    View in: PubMed
    Score: 0.006
  32. Comparison of endovascular treatment approaches for acute ischemic stroke: cost effectiveness, technical success, and clinical outcomes. J Neurointerv Surg. 2015 Sep; 7(9):666-70.
    View in: PubMed
    Score: 0.006
  33. Aggressive medical treatment with or without stenting in high-risk patients with intracranial artery stenosis (SAMMPRIS): the final results of a randomised trial. Lancet. 2014 Jan 25; 383(9914):333-41.
    View in: PubMed
    Score: 0.006
  34. Mechanisms of stroke after intracranial angioplasty and stenting in the SAMMPRIS trial. Neurosurgery. 2013 May; 72(5):777-95; discussion 795.
    View in: PubMed
    Score: 0.006
  35. Detailed analysis of periprocedural strokes in patients undergoing intracranial stenting in Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis (SAMMPRIS). Stroke. 2012 Oct; 43(10):2682-8.
    View in: PubMed
    Score: 0.006
  36. Utilization of CT perfusion patient selection for mechanical thrombectomy irrespective of time: a comparison of functional outcomes and complications. J Neurointerv Surg. 2013 Nov; 5(6):518-22.
    View in: PubMed
    Score: 0.006
  37. Executive summary: heart disease and stroke statistics--2012 update: a report from the American Heart Association. Circulation. 2012 Jan 03; 125(1):188-97.
    View in: PubMed
    Score: 0.005
  38. Heart disease and stroke statistics--2012 update: a report from the American Heart Association. Circulation. 2012 Jan 03; 125(1):e2-e220.
    View in: PubMed
    Score: 0.005
  39. CT perfusion-guided patient selection for endovascular treatment of acute ischemic stroke is safe and effective. J Neurointerv Surg. 2012 Jul; 4(4):261-5.
    View in: PubMed
    Score: 0.005
  40. Stenting versus aggressive medical therapy for intracranial arterial stenosis. N Engl J Med. 2011 Sep 15; 365(11):993-1003.
    View in: PubMed
    Score: 0.005
  41. Intracerebral hemorrhage: an unusual presentation of neurosarcoidosis. Neurologist. 2011 Sep; 17(5):292-6.
    View in: PubMed
    Score: 0.005
  42. Collaterals dramatically alter stroke risk in intracranial atherosclerosis. Ann Neurol. 2011 Jun; 69(6):963-74.
    View in: PubMed
    Score: 0.005
  43. Heart disease and stroke statistics--2011 update: a report from the American Heart Association. Circulation. 2011 Feb 01; 123(4):e18-e209.
    View in: PubMed
    Score: 0.005
  44. Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: a guideline for healthcare professionals from the american heart association/american stroke association. Stroke. 2011 Jan; 42(1):227-76.
    View in: PubMed
    Score: 0.005
  45. Risk factor status and vascular events in patients with symptomatic intracranial stenosis. Neurology. 2007 Nov 27; 69(22):2063-8.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.